125 related articles for article (PubMed ID: 37248414)
1. Microbiota metabolites as agonists for the orphan receptor GPRC5A.
Nat Chem Biol; 2023 Oct; 19(10):1183-1184. PubMed ID: 37248414
[No Abstract] [Full Text] [Related]
2. Chemoproteomics reveals microbiota-derived aromatic monoamine agonists for GPRC5A.
Zhao X; Stein KR; Chen V; Griffin ME; Lairson LL; Hang HC
Nat Chem Biol; 2023 Oct; 19(10):1205-1214. PubMed ID: 37248411
[TBL] [Abstract][Full Text] [Related]
3. Novel reciprocal regulation of cAMP signaling and apoptosis by orphan G-protein-coupled receptor GPRC5A gene expression.
Hirano M; Zang L; Oka T; Ito Y; Shimada Y; Nishimura Y; Tanaka T
Biochem Biophys Res Commun; 2006 Dec; 351(1):185-91. PubMed ID: 17055459
[TBL] [Abstract][Full Text] [Related]
4. Orphan G protein-coupled receptor GPRC5A modulates integrin β1-mediated epithelial cell adhesion.
Bulanova DR; Akimov YA; Rokka A; Laajala TD; Aittokallio T; Kouvonen P; Pellinen T; Kuznetsov SG
Cell Adh Migr; 2017 Sep; 11(5-6):434-446. PubMed ID: 27715394
[TBL] [Abstract][Full Text] [Related]
5. GPRC5A facilitates cell proliferation through cell cycle regulation and correlates with bone metastasis in prostate cancer.
Sawada Y; Kikugawa T; Iio H; Sakakibara I; Yoshida S; Ikedo A; Yanagihara Y; Saeki N; Győrffy B; Kishida T; Okubo Y; Nakamura Y; Miyagi Y; Saika T; Imai Y
Int J Cancer; 2020 Mar; 146(5):1369-1382. PubMed ID: 31276604
[TBL] [Abstract][Full Text] [Related]
6. GPRC5A is a potential oncogene in pancreatic ductal adenocarcinoma cells that is upregulated by gemcitabine with help from HuR.
Zhou H; Telonis AG; Jing Y; Xia NL; Biederman L; Jimbo M; Blanco F; Londin E; Brody JR; Rigoutsos I
Cell Death Dis; 2016 Jul; 7(7):e2294. PubMed ID: 27415424
[TBL] [Abstract][Full Text] [Related]
7. High prevalence of GPRC5A germline mutations in BRCA1-mutant breast cancer patients.
Sokolenko AP; Bulanova DR; Iyevleva AG; Aleksakhina SN; Preobrazhenskaya EV; Ivantsov AO; Kuligina ESh; Mitiushkina NV; Suspitsin EN; Yanus GA; Zaitseva OA; Yatsuk OS; Togo AV; Kota P; Dixon JM; Larionov AA; Kuznetsov SG; Imyanitov EN
Int J Cancer; 2014 May; 134(10):2352-8. PubMed ID: 24470238
[TBL] [Abstract][Full Text] [Related]
8. The emerging roles of GPRC5A in diseases.
Zhou H; Rigoutsos I
Oncoscience; 2014; 1(12):765-76. PubMed ID: 25621293
[TBL] [Abstract][Full Text] [Related]
9. Adaptive RSK-EphA2-GPRC5A signaling switch triggers chemotherapy resistance in ovarian cancer.
Moyano-Galceran L; Pietilä EA; Turunen SP; Corvigno S; Hjerpe E; Bulanova D; Joneborg U; Alkasalias T; Miki Y; Yashiro M; Chernenko A; Jukonen J; Singh M; Dahlstrand H; Carlson JW; Lehti K
EMBO Mol Med; 2020 Apr; 12(4):e11177. PubMed ID: 32115889
[TBL] [Abstract][Full Text] [Related]
10. RhoA/C inhibits proliferation by inducing the synthesis of GPRC5A.
Richter L; Oberländer V; Schmidt G
Sci Rep; 2020 Jul; 10(1):12532. PubMed ID: 32719397
[TBL] [Abstract][Full Text] [Related]
11. Identification and characterization of human PEIG-1/GPRC5A as a 12-O-tetradecanoyl phorbol-13-acetate (TPA) and PKC-induced gene.
Mori C; Valdivieso ÁG; Clauzure M; Massip-Copiz MM; Aguilar MÁ; Cafferata EGA; Santa Coloma TA
Arch Biochem Biophys; 2020 Jul; 687():108375. PubMed ID: 32339486
[TBL] [Abstract][Full Text] [Related]
12. Depletion of Gprc5a Promotes Development of Diabetic Nephropathy.
Ma X; Schwarz A; Sevilla SZ; Levin A; Hultenby K; Wernerson A; Lal M; Patrakka J
J Am Soc Nephrol; 2018 Jun; 29(6):1679-1689. PubMed ID: 29636387
[No Abstract] [Full Text] [Related]
13. NF-κB represses retinoic acid receptor-mediated GPRC5A transactivation in lung epithelial cells to promote neoplasia.
Song H; Ye X; Liao Y; Zhang S; Xu D; Zhong S; Jing B; Wang T; Sun B; Xu J; Guo W; Li K; Hu M; Kuang Y; Ling J; Zhang T; Wu Y; Du J; Yao F; Chin YE; Wang Q; Zhou BP; Deng J
JCI Insight; 2023 Jan; 8(1):. PubMed ID: 36413416
[TBL] [Abstract][Full Text] [Related]
14. Repression of G protein-coupled receptor family C group 5 member A is associated with pathologic differentiation grade of oral squamous cell carcinoma.
Liu SL; Zhong SS; Ye DX; Chen WT; Zhang ZY; Deng J
J Oral Pathol Med; 2013 Nov; 42(10):761-8. PubMed ID: 23651229
[TBL] [Abstract][Full Text] [Related]
15. GPRC5A: An emerging prognostic biomarker for predicting malignancy of Pancreatic Cancer based on bioinformatics analysis.
Qian X; Jiang C; Shen S; Zou X
J Cancer; 2021; 12(7):2010-2022. PubMed ID: 33753999
[No Abstract] [Full Text] [Related]
16. GPRC5A regulates proliferation and oxidative stress by inhibiting the STAT3/Socs3/c-MYC pathway in hepatocellular carcinoma.
Zhang L; Yang W; Yang J; Sun F
J Clin Biochem Nutr; 2023 Jul; 73(1):43-51. PubMed ID: 37534091
[TBL] [Abstract][Full Text] [Related]
17. GPRC5A exerts its tumor-suppressive effects in breast cancer cells by inhibiting EGFR and its downstream pathway.
Yang L; Ma T; Zhang J
Oncol Rep; 2016 Nov; 36(5):2983-2990. PubMed ID: 27599526
[TBL] [Abstract][Full Text] [Related]
18. Repression of GPRC5A is associated with activated STAT3, which contributes to tumor progression of head and neck squamous cell carcinoma.
Liu S; Ye D; Wang T; Guo W; Song H; Liao Y; Xu D; Zhu H; Zhang Z; Deng J
Cancer Cell Int; 2017; 17():34. PubMed ID: 28270740
[TBL] [Abstract][Full Text] [Related]
19. Clinical significance of reduced GPRC5A expression in surgically resected non-small cell lung cancer.
Jin E; Wang W; Fang M; Wang W; Xie R; Zhou H; Ye J; Xu R; Ma S
Oncol Lett; 2019 Jan; 17(1):502-507. PubMed ID: 30655793
[TBL] [Abstract][Full Text] [Related]
20. GPRC5A Is a Negative Regulator of the Pro-Survival PI3K/Akt Signaling Pathway in Triple-Negative Breast Cancer.
Yang L; Zhao S; Zhu T; Zhang J
Front Oncol; 2020; 10():624493. PubMed ID: 33680947
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
